about
Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantationHigh-risk childhood acute lymphoblastic leukemiaPharmacogenomics and individualized medicine: translating science into practice.Technical report: Ethical and policy issues in genetic testing and screening of children.Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia.Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia.Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.Therapy of Philadelphia chromosome-negative acute lymphoblastic leukemia in adults: new paradigms.Pharmacogenomics in acute myeloid leukemia.Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.Pharmacogenomics of pediatric acute lymphoblastic leukemia.Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.Pharmacogenetics of childhood acute lymphoblastic leukemia.HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial.Ordinary differential equations and Boolean networks in application to modelling of 6-mercaptopurine metabolism.
P2860
Q27002964-5C6E42CA-0E47-43ED-8D5F-D6DF36743D4CQ33622837-C020CA39-63B0-45A6-9CA6-75AA16911497Q34297575-3ADA0896-9A47-4D55-9323-B9897CBBB372Q34328987-3ADB7BDF-F7DE-481D-884F-2731C7DB2A11Q35684384-67F8234A-B83A-42AB-B336-32C341BEC3AEQ36286302-6E904421-BA7C-4348-AE52-96EDF9A1A04FQ37312970-92BDC041-7B44-4CB0-A967-85B237BB06DBQ37605864-9A7B24E4-F23F-4EFC-A0C1-E06CBF918377Q37627876-A8107FB5-D717-498A-91EA-925CA64F43B3Q37658863-724188AE-9144-45A9-B839-62F738695C94Q37739432-6CE6DBFA-9DDB-48B3-8A33-A46CCE2E323CQ38199738-FA716092-3CE7-4F4A-9F5B-ECA252B6FBC3Q38243175-0ADB3F19-CDC1-400A-8BF9-3000293C69D4Q41813372-15465BC9-69C8-4760-8C54-0C807C27FF6BQ42289833-D84B5F24-D99C-4351-86F2-D129AF672F95
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenetics in acute lymphoblastic leukemia.
@en
Pharmacogenetics in acute lymphoblastic leukemia.
@nl
type
label
Pharmacogenetics in acute lymphoblastic leukemia.
@en
Pharmacogenetics in acute lymphoblastic leukemia.
@nl
prefLabel
Pharmacogenetics in acute lymphoblastic leukemia.
@en
Pharmacogenetics in acute lymphoblastic leukemia.
@nl
P2093
P2860
P1476
Pharmacogenetics in acute lymphoblastic leukemia.
@en
P2093
Meyling H Cheok
Nicolas Pottier
William E Evans
P2860
P356
10.1053/J.SEMINHEMATOL.2008.09.002
P577
2009-01-01T00:00:00Z